Lepu Biopharma Co., Ltd. is focused on developing innovative biopharmaceuticals, particularly in the field of oncology. The company has established three key technology platforms: the Antibody-Drug Conjugate (ADC) technology platform, the antibody discovery platform, and the advanced process and analytical development platform. These platforms enable Lepu Biopharma to create a diverse pipeline of oncology products, including monoclonal antibodies, ADCs, immunotherapies, and oncolytic virus drugs. The ADC technology platform is particularly significant as it allows for the design and development of targeted therapeutics that can deliver drugs directly to cancer cells, thereby minimizing side effects and improving treatment efficacy.

In addition to its robust research and development capabilities, Lepu Biopharma has made significant investments in manufacturing infrastructure. The company operates a 2,000L GMP-compliant antibody production line in Beijing and is expanding its facilities in Shanghai, which will include a 12,000L capacity for antibody production. This strategic focus on in-house manufacturing not only supports clinical trials but also positions the company to meet the growing demand for its innovative therapies. With a strong intellectual property portfolio, including numerous patents granted in various jurisdictions, Lepu Biopharma is well-equipped to advance its mission of addressing unmet medical needs in cancer treatment.

China

Lepu Biopharma Co., Ltd. is an innovation-driven biopharmaceutical company focusing on oncology therapeutics with a strong China foundation and global vision. Our mission is to become a leading innovative company serving the unmet medical needs of cancer patients with first-in-class and best-in-class drugs. We strive to continuously develop a market differentiating pipeline by combining in-house research and development and strategic collaborations, strengthen in-house manufacturing, and commercialize our pipeline products through dedicated sales and marketing forces in China as well as via partnerships internationally.

Lepu Biopharma Co., Ltd

Company Details